Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Released May 15, 2026, during market hours
10-Q filed May 15, 2026, 45 days after period end · 0001493152-26-023615
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $458.54K | $436.38K | $336.97K | $360.99K |
| Net Income | $20.11K | -$38.56K | -$30.61K | $6.86K |
| EPS Diluted |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| $0.00 |
| -$0.01 |
| -$0.01 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
